Format

Send to

Choose Destination
JAMA. 2017 Jun 27;317(24):2479-2480. doi: 10.1001/jama.2017.5784.

Pharmaceutical Marketing for Rare Diseases: Regulating Drug Company Promotion in an Era of Unprecedented Advertisement.

Author information

1
Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
2
Knight Cancer Institute, Division of Hematology Oncology, Oregon Health & Science University, Portland3Department of Public Health and Preventive Medicine and Center for Health Care Ethics, Oregon Health & Science University, Portland.
PMID:
28520871
DOI:
10.1001/jama.2017.5784
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center